<bill session="114" type="h" number="5122" updated="2017-06-02T21:56:31Z">
  <state datetime="2016-04-29">REFERRED</state>
  <status>
    <introduced datetime="2016-04-29"/>
  </status>
  <introduced datetime="2016-04-29"/>
  <titles>
    <title type="official" as="introduced">To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.</title>
    <title type="display">To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.</title>
  </titles>
  <sponsor id="412427"/>
  <cosponsors>
    <cosponsor id="400004" joined="2016-07-13"/>
    <cosponsor id="412615" joined="2016-07-14"/>
    <cosponsor id="412625" joined="2016-07-13"/>
    <cosponsor id="412642" joined="2016-06-28"/>
    <cosponsor id="412250" joined="2016-07-13"/>
    <cosponsor id="400636" joined="2016-04-29"/>
    <cosponsor id="412539" joined="2016-07-13"/>
    <cosponsor id="400077" joined="2016-07-13"/>
    <cosponsor id="412658" joined="2016-09-09"/>
    <cosponsor id="412420" joined="2016-04-29"/>
    <cosponsor id="412275" joined="2016-07-13"/>
    <cosponsor id="412278" joined="2016-09-21"/>
    <cosponsor id="412290" joined="2016-09-09"/>
    <cosponsor id="412256" joined="2016-07-13"/>
    <cosponsor id="400659" joined="2016-07-13"/>
    <cosponsor id="400297" joined="2016-09-13"/>
    <cosponsor id="412303" joined="2016-07-13"/>
    <cosponsor id="400626" joined="2016-04-29"/>
    <cosponsor id="412393" joined="2016-07-13"/>
    <cosponsor id="400373" joined="2016-04-29"/>
    <cosponsor id="400406" joined="2016-07-13"/>
    <cosponsor id="400419" joined="2016-07-13"/>
  </cosponsors>
  <actions>
    <action datetime="2016-04-29">
      <text>Introduced in House</text>
    </action>
    <action datetime="2016-04-29" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2016-04-29">
      <text>Referred to House Energy and Commerce</text>
    </action>
    <action datetime="2016-04-29">
      <text>Referred to House Ways and Means</text>
    </action>
    <action datetime="2016-05-06">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2016-05-12">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" activity="Referral"/>
    <committee activity="Referral" code="HSWM02" subcommittee="Health" name="House Ways and Means"/>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug therapy"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2016-04-29T04:00:00Z" status="Introduced in House">This bill prohibits the Department of Health and Human Services from taking any further action on a proposed rule to change how Medicare pays for certain drugs that are typically not self-administered (such as some intravenous medications and chemotherapy drugs).</summary>
  <committee-reports/>
</bill>
